260 related articles for article (PubMed ID: 6370012)
1. High-dose melphalan therapy for the treatment of children with refractory neuroblastoma and Ewing's sarcoma.
Graham-Pole J; Lazarus HM; Herzig RH; Gross S; Coccia P; Weiner R; Strandjord S
Am J Pediatr Hematol Oncol; 1984; 6(1):17-26. PubMed ID: 6370012
[TBL] [Abstract][Full Text] [Related]
2. Megachemotherapy followed by autologous stem cell transplantation in children with Ewing's sarcoma.
Drabko K; Zawitkowska-Klaczynska J; Wojcik B; Choma M; Zaucha-Prazmo A; Kowalczyk J; Gorczynska E; Toporski J; Kałwak K; Turkiewicz D; Chybicka A
Pediatr Transplant; 2005 Oct; 9(5):618-21. PubMed ID: 16176419
[TBL] [Abstract][Full Text] [Related]
3. Treatment of Ewing's sarcoma with high-dose melphalan and autologous bone marrow transplantation.
Cornbleet MA; Corringham RE; Prentice HG; Boesen EM; McElwain TJ
Cancer Treat Rep; 1981; 65(3-4):241-4. PubMed ID: 7016319
[TBL] [Abstract][Full Text] [Related]
4. High-dose sequential chemotherapy and autologous stem cell reinfusion in advanced pediatric solid tumors.
Chan KW; Petropoulos D; Choroszy M; Herzog C; Jaffe N; Ater J; Korbling M
Bone Marrow Transplant; 1997 Dec; 20(12):1039-43. PubMed ID: 9466276
[TBL] [Abstract][Full Text] [Related]
5. [High-dosage melphalan followed by bone marrow autotransplant in solid tumors of childhood: our experience].
Sánchez de Toledo Codina J; Gallego Melcón S; Pérez Payarols J; Prats Viñas J; Javier G; Massuet L; Macià Martí J
Med Clin (Barc); 1986 Apr; 86(15):621-3. PubMed ID: 3014240
[No Abstract] [Full Text] [Related]
6. High-dose busulphan/melphalan with autologous stem cell rescue in Ewing's sarcoma.
Atra A; Whelan JS; Calvagna V; Shankar AG; Ashley S; Shepherd V; Souhami RL; Pinkerton CR
Bone Marrow Transplant; 1997 Nov; 20(10):843-6. PubMed ID: 9404924
[TBL] [Abstract][Full Text] [Related]
7. Intensive chemotherapy with stem cell support-experience in pediatric solid tumours.
Pinkerton CR
Bull Cancer; 1995; 82 Suppl 1():61s-65s. PubMed ID: 7626856
[TBL] [Abstract][Full Text] [Related]
8. High-dose busulfan/melphalan as conditioning for autologous PBPC transplantation in pediatric patients with solid tumors.
Diaz MA; Vicent MG; Madero L
Bone Marrow Transplant; 1999 Dec; 24(11):1157-9. PubMed ID: 10642802
[TBL] [Abstract][Full Text] [Related]
9. High-dose therapy for patients with primary multifocal and early relapsed Ewing's tumors: results of two consecutive regimens assessing the role of total-body irradiation.
Burdach S; Meyer-Bahlburg A; Laws HJ; Haase R; van Kaik B; Metzner B; Wawer A; Finke R; Göbel U; Haerting J; Pape H; Gadner H; Dunst J; Juergens H
J Clin Oncol; 2003 Aug; 21(16):3072-8. PubMed ID: 12915596
[TBL] [Abstract][Full Text] [Related]
10. [High-dose chemotherapy with autologous peripheral blood stem cell transplantation (PBSCT) for refractory bone and soft tissue sarcomas].
Yonemoto T; Tatezaki S; Ishii T; Satoh T
Gan To Kagaku Ryoho; 1999 Sep; 26(10):1431-5. PubMed ID: 10500530
[TBL] [Abstract][Full Text] [Related]
11. Treatment of metastatic Ewing's sarcoma or primitive neuroectodermal tumor of bone: evaluation of combination ifosfamide and etoposide--a Children's Cancer Group and Pediatric Oncology Group study.
Miser JS; Krailo MD; Tarbell NJ; Link MP; Fryer CJ; Pritchard DJ; Gebhardt MC; Dickman PS; Perlman EJ; Meyers PA; Donaldson SS; Moore S; Rausen AR; Vietti TJ; Grier HE
J Clin Oncol; 2004 Jul; 22(14):2873-6. PubMed ID: 15254055
[TBL] [Abstract][Full Text] [Related]
12. Ewing's sarcoma of the foot.
Adkins CD; Kitaoka HB; Seidl RK; Pritchard DJ
Clin Orthop Relat Res; 1997 Oct; (343):173-82. PubMed ID: 9345223
[TBL] [Abstract][Full Text] [Related]
13. Improved relapse free survival in patients with poor prognosis Ewing's sarcoma after consolidation with hyperfractionated total body irradiation and fractionated high dose melphalan followed by high dose etoposide and hematopoietic rescue.
Burdach S; Peters C; Paulussen M; Nürnberger W; Wurm R; Wernet P; Dilloo D; Voehringer R; Gadner H; Göbel U
Bone Marrow Transplant; 1991; 7 Suppl 2():95. PubMed ID: 1678978
[No Abstract] [Full Text] [Related]
14. [Long-term results following multidisciplinary treatment of localized Ewing's sarcoma in children and adolescents].
Ullmann C; Beck JD; Holter W; Petsch S; Dunst J; Sauer R; Grabenbauer GG
Strahlenther Onkol; 2008 Mar; 184(3):137-44. PubMed ID: 18330509
[TBL] [Abstract][Full Text] [Related]
15. [The European experience with megadose therapy and autologous bone marrow transplantation in solid tumors with poor prognosis Ewing sarcoma, germ cell tumors and brain tumors)].
Ladenstein R; Gadner H; Hartmann O; Pico J; Biron P; Thierry P
Wien Med Wochenschr; 1995; 145(2-3):55-7. PubMed ID: 7762255
[TBL] [Abstract][Full Text] [Related]
16. [Treatment of Ewing's sarcoma in children].
Timukhina VN
Med Radiol (Mosk); 1985 Dec; 30(12):7-11. PubMed ID: 4079697
[No Abstract] [Full Text] [Related]
17. Pattern of relapse in 290 patients with nonmetastatic Ewing's sarcoma family tumors treated at a single institution with adjuvant and neoadjuvant chemotherapy between 1972 and 1999.
Bacci G; Longhi A; Ferrari S; Mercuri M; Barbieri E; Bertoni F; Bacchini P; Picci P
Eur J Surg Oncol; 2006 Nov; 32(9):974-9. PubMed ID: 16621429
[TBL] [Abstract][Full Text] [Related]
18. Impact of high-dose busulfan plus melphalan as consolidation in metastatic Ewing tumors: a study by the Société Française des Cancers de l'Enfant.
Oberlin O; Rey A; Desfachelles AS; Philip T; Plantaz D; Schmitt C; Plouvier E; Lejars O; Rubie H; Terrier P; Michon J;
J Clin Oncol; 2006 Aug; 24(24):3997-4002. PubMed ID: 16921053
[TBL] [Abstract][Full Text] [Related]
19. Phase II trial of topotecan administered as 72-hour continuous infusion in children with refractory solid tumors: a collaborative Pediatric Branch, National Cancer Institute, and Children's Cancer Group Study.
Blaney SM; Needle MN; Gillespie A; Sato JK; Reaman GH; Berg SL; Adamson PC; Krailo MD; Bleyer WA; Poplack DG; Balis FM
Clin Cancer Res; 1998 Feb; 4(2):357-60. PubMed ID: 9516923
[TBL] [Abstract][Full Text] [Related]
20. Intensive melphalan chemotherapy and cryopreserved autologous bone marrow transplantation for the treatment of refractory cancer.
Lazarus HM; Herzig RH; Graham-Pole J; Wolff SN; Phillips GL; Strandjord S; Hurd D; Forman W; Gordon EM; Coccia P
J Clin Oncol; 1983 Jun; 1(6):359-67. PubMed ID: 6366139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
